Clinical trial
A Phase Two Study Of Fenretinide In Renal Cell Cancer
NCT00011973 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Two Study Of Fenretinide In Renal Cell Cancer
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2000
- Completion date
- October 31, 2005
- Enrollment
- Not reported
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer